Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
179.00    0.00 (0.00%)
Bid:
179.00
Ask:
184.00
Spread: 5.00 (2.793%)
Market Cap: £34.79m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Hedging Strategy Update

7 Mar 2018 07:00

RNS Number : 9014G
Palace Capital PLC
07 March 2018
 

Palace Capital PLC

("Palace Capital", the "Company" or the "Group")

 

Hedging Strategy Update

 

Palace Capital plc, the property investment company that focuses on commercial property predominantly outside London, announces that it has entered into further hedging facilities totalling £55.8 million in order to mitigate future interest rate risk.

 

The Company has now executed swaps for approximately 70 per cent. of Group drawn debt facilities, equating to £70.3 million, due to the recent increase in expectations that UK interest rates will rise in the short to medium term. The Board concluded that it was prudent to fix the interest rates on the majority of its debt facilities in order to give the Company protection against higher rates and limit its exposure to movements in LIBOR. As a result, the Group's average cost of debt, going forward, has increased from 2.9 per cent. to 3.4 per cent.

 

JC Rathbone Associates Limited ("Rathbone") provided hedging advice to the Board. The hedging that has been entered into requires a fair value assessment at each of the Company's future reporting dates and Rathbone will provide this to the Group.

 

Stephen Silvester, Finance Director, commented: "We have had one of the consistently lowest costs of debt in the sector in recent years. Given the advice from Rathbone and market expectations concerning interest rates, we agreed that locking-in the majority of our debt on fixed rates provides the Company with limited exposure to future interest rate risk whilst maintaining our relative cost of funds position and good headroom with regards to interest cover."

 

In relation to the proposed admission of the Company's shares to the premium listing segment of the Official List of the FCA and admission to trading on its Main Market for listed securities, a supplementary Prospectus will be published as soon as practicable and made available on the Company's website at www.palacecapitalplc.com.

 

Date: 7 March 2018

 

For further information, contact:

 

Palace Capital plc

Neil Sinclair, Chief Executive

Stephen Silvester, Finance Director

Tel. +44 (0)20 3301 8331

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Nick Naylor / James Reeve / Asha Chotai

Tel. +44 (0)20 3328 5656

 

Arden Partners plc (Joint Broker)

Chris Hardie / Ciaran Walsh

Tel. +44 (0)207 614 5917

 

Capital Access Group (Financial PR)

Scott Fulton

Tel. +44 (0)20 3763 3400

 

About Palace Capital plc (www.palacecapitalplc.com):

 

Palace Capital is a UK property investment company admitted to trading on the AIM Market of the London Stock Exchange (LSE: PCA). The Company is not sector specific and looks for opportunities where it can enhance the long-term income and capital value through asset management and strategic capital development in locations outside London. In its last reported financial year, Palace Capital produced a 20.0% increase in adjusted profit before tax, a 7.0% uplift in EPRA NAV per share and a 16.0% increase in dividends.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNAWRWSAORAR
Date   Source Headline
26th Jul 20232:15 pmRNSResult of AGM
26th Jul 20237:00 amRNSAGM Trading Update
19th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20237:00 amRNSShare Buyback and Total Voting Rights
30th Jun 20237:00 amRNSTransaction in Own Shares
28th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSAnnual Report and Notice of Annual General Meeting
23rd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares
15th Jun 202311:21 amRNSShare Buyback
15th Jun 20237:00 amRNSResults for the year ended 31 March 2023
6th Jun 20237:00 amRNSTransaction in Own Shares
25th May 20237:00 amRNSTransaction in Own Shares
17th May 20237:00 amRNSTransaction in Own Shares
15th May 20237:00 amRNSTransaction in Own Shares
12th May 20237:00 amRNSTransaction in Own Shares
5th May 20237:00 amRNSIndustrial properties disposal and Trading Update
18th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20232:30 pmRNSHolding(s) in Company
21st Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 20237:00 amRNSDividend Declaration
14th Feb 20237:00 amRNSIndustrial property disposal
6th Feb 20237:00 amRNSShare Buyback
22nd Dec 20227:00 amRNSDisposals and Debt Position Update
25th Nov 20224:40 pmRNSSecond Price Monitoring Extn
25th Nov 20224:35 pmRNSPrice Monitoring Extension
24th Nov 20227:00 amRNSInterim Results
20th Oct 202212:03 pmRNSDirector Dealing
18th Oct 20223:49 pmRNSHolding(s) in Company
12th Oct 20227:00 amRNSTrading Update
15th Sep 20227:00 amRNSDividend Declaration
18th Aug 20222:51 pmRNSDirector Dealing
12th Aug 20227:00 amRNSBoard change
2nd Aug 20227:00 amRNSBoard change
29th Jul 20223:18 pmRNSResult of AGM
28th Jul 20221:39 pmRNSHolding(s) in Company
20th Jul 20226:04 pmRNSDirector Dealing
19th Jul 20227:00 amRNSFurther Update on Strategy and Changes to Board
15th Jul 20224:27 pmRNSHolding(s) in Company
13th Jul 202211:58 amRNSHolding(s) in Company
12th Jul 20223:36 pmRNSHolding(s) in Company
12th Jul 20229:50 amRNSHolding(s) in Company
12th Jul 20227:00 amRNSTransaction in Own Shares
4th Jul 20227:01 amRNSCommencement of share buyback
4th Jul 20227:00 amRNSUpdate on Strategy
28th Jun 202210:27 amRNSAnnual Report and Notice of Annual General Meeting
14th Jun 20222:10 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.